Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Patent: 2 | |||
2 | Patent: 1 | |||
3 | Tokyo, Japan | Patent: 1 | ||
4 | Patent: 1 | |||
5 | Tokyo, Japan | Patent: 1 | ||
6 | Patent: 1 | |||
7 | Patent: 1 | |||
8 | Patent: 1 | |||
9 | Patent: 1 | |||
10 | Patent: 1 |
Top 10 Fast-growings companies in Voglibose
by Most Patent Filing In 5 Years in the world in 2022
The Voglibose top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years Voglibose Fast-growings in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company. Voglibose was first launched in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus.
Page generation time:
Aug 03 2025